Efficacy and Safety of Leuprolide Acetate 3 Month Depot 11.25 or 30 mg for the Treatment of Central Precocious Puberty.

被引：0
|
作者：
Lee, P. A. [1 ]
Klein, K. [2 ]
Mauras, N. [3 ]
Yang, D. [4 ]
Mattia-Goldberg, C. [4 ]
Chwalisz, K. [4 ]
机构：
[1] Penn State Coll Med, Hershey, PA USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Nemours Childrens Hosp, Jacksonville, FL USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty
    Lee, Peter A.
    Klein, Karen
    Mauras, Nelly
    Neely, E. Kirk
    Bloch, Clifford A.
    Larsen, Lois
    Mattia-Goldberg, Cynthia
    Chwalisz, Kristof
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1572 - 1580
  • [2] EFFICACY OF DEPOT LEUPROLIDE ACETATE IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY
    NEELY, EK
    WILSON, DM
    BACHRACH, LK
    ROSENFELD, RG
    COHEN, P
    SMITH, JK
    HINTZ, RL
    PEDIATRIC RESEARCH, 1991, 29 (04) : A83 - A83
  • [3] Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study
    Klein, Karen O.
    Mauras, Nelly
    Nayak, Sunil
    Sunil, Bhuvana
    Martinez-Placencia, Blanca M.
    Dragnic, Sanja
    Ballina, Mayra
    Zhou, Qing
    Kansra, Alvina R.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (07)
  • [4] EFFICACY OF DEPOT LEUPROLIDE ACETATE THERAPY FOR CENTRAL PRECOCIOUS PUBERTY
    COOK, JS
    CHAPLER, G
    KELLY, L
    CONN, PM
    HANSEN, JR
    CLINICAL RESEARCH, 1990, 38 (03): : A860 - A860
  • [5] Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg)
    Carel, JC
    Lahlou, N
    Jaramillo, O
    Montauban, V
    Teinturier, C
    Colle, M
    Lucas, C
    Chaussain, JL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4111 - 4116
  • [6] Treatment of central precocious puberty with triptorelin 11.25 mg depot formulation
    Martinez-Aguayo, A.
    Hernandez, M. I.
    Beas, F.
    Iniguez, G.
    Avila, A.
    Sovino, H.
    Bravo, E.
    Cassorla, F.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (08): : 963 - 970
  • [7] DEPOT LEUPROLIDE ACETATE FOR TREATMENT OF PRECOCIOUS PUBERTY
    PARKER, KL
    LEE, PA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03): : 689 - 691
  • [8] Efficacy and Safety of the First 6-Month Subcutaneous Leuprolide Acetate for Treatment of Central Precocious Puberty
    Klein, Karen Oerter
    Miller, Bradley
    Benson, Matthew
    Kletter, Gad B.
    Mauras, Netly
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 171 - 172
  • [9] 6-month Leuprolide Acetate for Monitoring Central Precocious Puberty Treatment Efficacy
    Silverman, Lawrence
    Boldt-Houle, Deborah M.
    Atkinson, Stuart N.
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 208 - 209
  • [10] Anthropometric, metabolic, and reproductive outcomes of patients with central precocious puberty treated with leuprorelin acetate 3-month depot (11.25 mg)
    Ramos, Carolina O.
    Canton, Ana P. M.
    Seraphim, Carlos Eduardo
    Faria, Aline Guimaraes
    Tinano, Flavia Rezende
    Mendonca, Berenice B.
    Latronico, Ana C.
    Brito, Vinicius N.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (11): : 1371 - 1377
12345